trending Market Intelligence /marketintelligence/en/news-insights/trending/3gHsHPQtAuQpgHaUFf_jtA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Israel's Taro completes $250M share buyback program

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Israel's Taro completes $250M share buyback program

Taro Pharmaceutical Industries Ltd. completed a $250 million share buyback program which was announced in November 2016.

The Israeli pharmaceutical company bought back 2,493,378 ordinary shares at an average price of $100.28 per share.